Predictors included in the final models were age (as continuous variable), mode of detection (screening through the national programme or clinically detected), histology, tumour sublocalisation, grade, pT, pN, hormonal receptor status ± endocrine treatment, HER2 status ± targeted treatment, surgery ± immediate breast reconstruction ± radiation therapy, and chemotherapy. This evidence concerns the gene ERBB2 and neoplasm.